Form 4: Cero Therapeutics Holdings Director Acquires Stock Options

Director Shami Patel acquires stock options in Cero Therapeutics Holdings, Inc.

Summary

• On March 4, 2025, Shami Patel, a director of Cero Therapeutics Holdings, Inc., acquired stock options representing the right to buy 14,936 shares of common stock.
• The exercise price of these options is $1.43.
• The options vest over time, with 50% vesting on the twelve-month anniversary of the grant date and the remaining portion subject to performance conditions.
• The options expire on March 3, 2035.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine disclosure of stock option grants to a director.

Industry Context

This is a standard SEC Form 4 filing, indicating a change in beneficial ownership by a company insider. It's common for directors and officers to receive stock options as part of their compensation.

Stakeholder Impact

• The granting of stock options to a director can align their interests with those of shareholders, as the value of the options increases if the company's stock price increases.

Key Dates

Keywords

stock options, Form 4, Cero Therapeutics Holdings, insider trading, beneficial ownership, Shami Patel, director